Type 2 Diabetes

>

Latest News

The HCPFive: Top News for Healthcare Providers from the Week of 02/16 | Image Credit: HCPLive
The HCPFive: Top News for Healthcare Providers from the Week of 02/16

February 22nd 2025

Our top 5 headlines included a new approval for atopic dermatitis, expert consensus on anaphylaxis care, and the end of the semaglutide shortage.

FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy) | Image Credit: US Food and Drug Administration
FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy)

February 21st 2025

Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD | Image Credit: Mount Sinai
Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD

February 18th 2025

FDA
FDA Approves Merilog, Biosimilar Product of Insulin Aspart (Novolog) for Diabetes

February 14th 2025

CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes | Image Credit: LinkedIn
CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes

February 11th 2025

<1
...
132133134135136
© 2025 MJH Life Sciences

All rights reserved.